Narrative review / 2010
Dietary L-arginine supplementation reduces adiposity and improves metabolic profiles in animal models and obese humans with type 2 diabetes.
This review discusses evidence regarding the nutritional and therapeutic roles of L-arginine in treating metabolic disorders. Emerging evidence indicates that dietary L-arginine supplementation reduces adiposity in genetically obese rats, diet-induced obese rats, finishing pigs, and obese humans with type 2 diabetes mellitus. Mechanisms likely involve altering energy balance toward fat loss, stimulating mitochondrial biogenesis and brown adipose tissue development, and increasing expression of genes promoting glucose and fatty acid oxidation.
- Study type
- Narrative review
- Who was studied
- Animals and obese human subjects with Type-2 diabetes mellitus
- What was measured
- Adiposity, muscle mass, metabolic profile, mitochondrial biogenesis
THE PAPER
Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health.
McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Spencer TE, Meininger CJ, McNeal CJ, Wu G. Amino Acids, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.